SALT Study (Switching to the Administration of Lithium Slow -Release Treatment)

NCT03210480 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

85

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision due to slow enrollment rate.

Conditions

Bipolar Disorder

Interventions

DRUG: Lithium sulphate prolonged-release 660 mg
DRUG: Lithium carbonate immediate-release 150 mg and 300 mg

Sponsor

Aziende Chimiche Riunite Angelini Francesco S.p.A

Collaborators

[object Object]